Thus, the relationshipbetween overexpression and/or amplification of ErbB2 and a poor clinicalprognosis suggests that ErbB2 is an important link in the molecular biologicalclassification of breast cancers and an important therapeutic target.Currently, there are drugs whose action targets ErbB2. The gene discussed is ERBB2; the disease is breast carcinoma.